No benefit of alteplase in mild stroke with non-disabling symptoms

Alteplase does not appear to benefit patients with mild acute ischaemic stroke presenting with initially minor neurologic deficits. The findings, from the prematurely terminated PRISMS trial, support current practice and should help reassure clinicians in managing this sub-group of stroke patients with a low NIH Stroke Scale score and non-disabling symptoms. The data, from the ...

Already a member?

Login to keep reading.

© 2022 the limbic